Screener
Moderna MRNA Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's finance lease liabilities?
- Moderna (MRNA) reported finance lease liabilities of $6M in Q2 2026.
- How has Moderna's finance lease liabilities changed year-over-year?
- Moderna's finance lease liabilities decreased by 81.3% year-over-year, from $32M to $6M.
- What is the long-term trend for Moderna's finance lease liabilities?
- Over 5 years (2020 to 2025), Moderna's finance lease liabilities has grown at a -28.9% compound annual growth rate (CAGR), from $110M to $20M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Moderna's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude